AU1216783A - 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas - Google Patents

1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas

Info

Publication number
AU1216783A
AU1216783A AU12167/83A AU1216783A AU1216783A AU 1216783 A AU1216783 A AU 1216783A AU 12167/83 A AU12167/83 A AU 12167/83A AU 1216783 A AU1216783 A AU 1216783A AU 1216783 A AU1216783 A AU 1216783A
Authority
AU
Australia
Prior art keywords
diethylureas
ergolinyl
8alpha
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12167/83A
Other versions
AU555961B2 (en
Inventor
Antonin Cerny
Jiri Krepelka
Karel Rezabek
Miroslav Seda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Original Assignee
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Spojene Podniky Pro Zdravotnickou Vyrobu filed Critical Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Publication of AU1216783A publication Critical patent/AU1216783A/en
Application granted granted Critical
Publication of AU555961B2 publication Critical patent/AU555961B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12167/83A 1982-03-12 1983-03-08 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas Ceased AU555961B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS821734A CS231214B1 (en) 1982-03-12 1982-03-12 Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea

Publications (2)

Publication Number Publication Date
AU1216783A true AU1216783A (en) 1983-09-15
AU555961B2 AU555961B2 (en) 1986-10-16

Family

ID=5352449

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12167/83A Ceased AU555961B2 (en) 1982-03-12 1983-03-08 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas

Country Status (15)

Country Link
JP (1) JPS58180484A (en)
AT (1) AT383349B (en)
AU (1) AU555961B2 (en)
BE (1) BE896122A (en)
CA (1) CA1203531A (en)
CH (1) CH652125A5 (en)
CS (1) CS231214B1 (en)
DE (1) DE3308719A1 (en)
DK (1) DK84683A (en)
FI (1) FI830754L (en)
FR (1) FR2523131B1 (en)
GB (1) GB2116548B (en)
IT (1) IT1161209B (en)
NL (1) NL8300829A (en)
SE (1) SE452321B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU567333B2 (en) * 1983-03-14 1987-11-19 Schering Aktiengesellschaft Lysergic acid derivatives

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
DE3522894A1 (en) * 1985-06-24 1987-01-02 Schering Ag USE OF TERGURID AS GERIATRIC
FR2584720B1 (en) * 1985-07-11 1987-10-02 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF N-METHYL DERIVATIVES OF ERGOLINE
DE3620293A1 (en) * 1986-06-16 1987-12-17 Schering Ag 1 AND / OR 2 SUBSTITUTED ERGOL DERIVATIVES
DE3623503A1 (en) * 1986-07-09 1988-01-21 Schering Ag 1-ARYL-ERGOLINYL-UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE OF THESE COMPOUNDS AS A MEDICINAL PRODUCT
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine
US20140058108A1 (en) * 2010-11-11 2014-02-27 Sinoxa Pharma Ug Lisuride, Terguride and Derivatives Thereof for Use in the Prophylaxis and/or Treatment of Fibrotic Changes
BR112017015487A2 (en) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc COMPOUND; COMPOSITION; METHOD OF TREATMENT AND / OR PREVENTION OF MIGRAINE, ALS, ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, EXTRAPYRIMIDAL DISORDERS, DEPRESSION, NAUSEA, AEMESIS, SYNDROME OF THE WASTE LEGS, INSOMENESS, HYGERNESS, AGING , ANXIETY, DRUG DEPENDENCIES, DYSTONIA, PARASSONIA OR HYPERLACTINEMIA IN AN INDIVIDUAL; AGONIZATION METHODS OF D2, 5-HT1D, 5-HT1A AND 5-HT2C RECEPTORS, IN AN INDIVIDUAL; ANTAGONIZATION METHOD OF THE D3 RECEPTOR IN AN INDIVIDUAL; METHODS OF SELECTIVE AGONIZATION OF RECEPTORS 5 -HT1D, AND 5-HT2C, METHOD OF PROVIDING FUNCTIONAL ANTAGONIST ACTIVITY IN RECEPTOR 5 -HT2B OR IN RECEIVER 5-HT7, OR IN BOTH, IN AN INDIVIDUAL; METHOD OF PROVIDING FUNCTIONAL ANTAGONIST ACTIVITY IN ADRENERGIC RECEPTORS IN AN INDIVIDUAL
MX2017009406A (en) 2015-01-20 2018-01-18 Xoc Pharmaceuticals Inc Isoergoline compounds and uses thereof.
BR112019025420A2 (en) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. POLYCYCLICAL COMPOUNDS AND USES OF THESE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH344731A (en) * 1956-05-18 1960-02-29 Sandoz Ag Process for the production of new derivatives of the lysergic acid series alkylated on the indole nitrogen
AT231082B (en) * 1960-10-12 1964-01-10 Sandoz Ag Process for the production of new urea derivatives
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU567333B2 (en) * 1983-03-14 1987-11-19 Schering Aktiengesellschaft Lysergic acid derivatives

Also Published As

Publication number Publication date
AU555961B2 (en) 1986-10-16
AT383349B (en) 1987-06-25
SE8301257L (en) 1983-09-13
FI830754L (en) 1983-09-13
DE3308719A1 (en) 1983-09-22
SE452321B (en) 1987-11-23
IT8319935A0 (en) 1983-03-07
CS231214B1 (en) 1984-10-15
DK84683D0 (en) 1983-02-24
CH652125A5 (en) 1985-10-31
NL8300829A (en) 1983-10-03
FR2523131A1 (en) 1983-09-16
JPS58180484A (en) 1983-10-21
ATA72783A (en) 1986-11-15
BE896122A (en) 1983-07-01
GB2116548A (en) 1983-09-28
GB2116548B (en) 1985-03-20
DK84683A (en) 1983-09-13
FI830754A0 (en) 1983-03-07
SE8301257D0 (en) 1983-03-08
CA1203531A (en) 1986-04-22
IT1161209B (en) 1987-03-18
GB8305735D0 (en) 1983-04-07
FR2523131B1 (en) 1987-08-28

Similar Documents

Publication Publication Date Title
AU1023483A (en) N-arylsulfonyl-n:-pyrimidinyl ureas
AU555961B2 (en) 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas
AU1270583A (en) 3-azolyl-1,2-diaryl-1-halogenoprop-1-enes
AU565667B2 (en) N, n-di-n-propyl-4-hydroxy-3- methanesulphonamidophenethylamine
AU561449B2 (en) Pharmaceutical 3-aryl-7-chloro-9-oxo-3,4-dihyroacridines
AU561832B2 (en) 1-(alkyl-phenoxyaryl)-3-benzoyl ureas
AU2410284A (en) Capstanspil, navnlig til sejlbade
AU1792983A (en) 2,3-dihydrobenzofurans
AU553831B2 (en) N,n-disubstituted azolecarboxamides
AU562725B2 (en) 16-fluoro-16, 17-didehydro-prostanoids
AU563881B2 (en) Carbacycline, preparation and utilization thereof
AU1505783A (en) Spanner
AU563276B2 (en) 1 - substituted azacycloalkan - z ones
AU540498B2 (en) N-substituted 2-amino-3,4-dihydro-pyridives
AU554684B2 (en) N-(2-methyl-5-chlorophenyl)-n-methoxyacetyl-3-amino- 1,3-oxazolydin-2-one
AU1734183A (en) 3alpha-(substituted-phenyl)-3alpah,4,7,7alpha-tetrahydro-4, 7-methanoisoindolines
AU551883B2 (en) 2,5-bis-perfluoroalkyl-3,4-dicarbonylalkoxypyrroles
AU563809B2 (en) 3-acyl-2-nitromethylene-tetrahydro-2h-1,3-thiazines
AU568648B2 (en) 1,2,3-thiazole-3-in-5-ylidine ureas
AU1176983A (en) 2,3-dihydro-1h-pyrrolizines
AU572822B2 (en) N,n-diethyl-ergolin-8-yl-sulphamide
AU1302883A (en) 1,3,5-triacrylylhexahydro-s-triazines
AU6657581A (en) N-(tetrahydro-2-oxo-3-furyl)-2:,6:acetoxylidide
AU1617483A (en) Ureas
AU1340183A (en) Alpha-halo-n,n-dimethylpropionamides